Centaur Pharmaceutical Pvt. Ltd.
Records under this name other than patents Centaur Pharmaceutical Pvt. Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Centaur Pharmaceutical Pvt. Ltd.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,786,304 | Process for the preparation of eszopiclone Lapsed on the fee record Ended Aug 31, 2014 · From the USPTO record | Lapsed on the fee record | Ended Aug 31, 2014 | From the USPTO record |
| US 6,441,032 | Alpha-(4-Ethoxyphenyl)-N-tert-butylnitrone, pharmaceutical compositions and their medical use Lapsed on the fee record Ended Aug 27, 2014 · From the USPTO record | Lapsed on the fee record | Ended Aug 27, 2014 | From the USPTO record |
| US 6,689,911 | Novel Process Lapsed on the fee record Ended Feb 10, 2012 · High confidence | Lapsed on the fee record | Ended Feb 10, 2012 | High confidence |
| US 6,486,349 | Amide therapeutics and methods for treating inflammatory bowel disease Lapsed on the fee record Ended Nov 26, 2010 · From the USPTO record | Lapsed on the fee record | Ended Nov 26, 2010 | From the USPTO record |
| US 6,433,008 | &agr;-aryl-N-alkylnitrones and pharmaceutical compositions containing the same Lapsed on the fee record Ended Aug 13, 2010 · From the USPTO record | Lapsed on the fee record | Ended Aug 13, 2010 | From the USPTO record |
| US 6,376,540 | Furan nitrone compounds Lapsed on the fee record Ended Apr 23, 2010 · From the USPTO record | Lapsed on the fee record | Ended Apr 23, 2010 | From the USPTO record |
| US 6,342,523 | 3,4,5-trisubstituted aryl nitrone compounds, pharmaceutical compositions containing the same and methods for treating inflammation Lapsed on the fee record Ended Jan 29, 2010 · From the USPTO record | Lapsed on the fee record | Ended Jan 29, 2010 | From the USPTO record |
| US 6,310,092 | Methods for preventing and treating autoimmune and inflammatory disease using thioether furan nitrone compounds Lapsed on the fee record Ended Oct 30, 2009 · From the USPTO record | Lapsed on the fee record | Ended Oct 30, 2009 | From the USPTO record |
| US 6,271,265 | Amide therapeutics for the treatment of inflammatory bowel disease Lapsed on the fee record Ended Aug 7, 2009 · From the USPTO record | Lapsed on the fee record | Ended Aug 7, 2009 | From the USPTO record |
| US 6,258,852 | Aryl nitrone therapeutics for the treatment of inflammatory bowel disease Lapsed on the fee record Ended Jul 10, 2009 · From the USPTO record | Lapsed on the fee record | Ended Jul 10, 2009 | From the USPTO record |